Low-dose liposomal amphotericin B in refractory Indian visceral leishmaniasis: a multicenter study.

S SundarKala-azar Medical Research Center, Banaras Hindu University, Varanasi, India. shyam_vns@satyam.net.in

Search for other papers by S Sundar in
Current site
Google Scholar
PubMed
Close
,
T K JhaKala-azar Medical Research Center, Banaras Hindu University, Varanasi, India. shyam_vns@satyam.net.in

Search for other papers by T K Jha in
Current site
Google Scholar
PubMed
Close
,
C P ThakurKala-azar Medical Research Center, Banaras Hindu University, Varanasi, India. shyam_vns@satyam.net.in

Search for other papers by C P Thakur in
Current site
Google Scholar
PubMed
Close
,
M MishraKala-azar Medical Research Center, Banaras Hindu University, Varanasi, India. shyam_vns@satyam.net.in

Search for other papers by M Mishra in
Current site
Google Scholar
PubMed
Close
,
V R SinghKala-azar Medical Research Center, Banaras Hindu University, Varanasi, India. shyam_vns@satyam.net.in

Search for other papers by V R Singh in
Current site
Google Scholar
PubMed
Close
, and
R BuffelsKala-azar Medical Research Center, Banaras Hindu University, Varanasi, India. shyam_vns@satyam.net.in

Search for other papers by R Buffels in
Current site
Google Scholar
PubMed
Close

In this randomized, double-blind, dose-ranging, multicenter trial, 84 patients with visceral leishmaniasis refractory to antimony therapy were administered liposomal amphotericin B (AmBisome) at cumulative doses of 3.75, 7.5, and 15.0 mg/kg for 5 consecutive days. Posttreatment apparent cure and definite cure were assessed at 2 weeks and 6 months after the end of therapy, respectively. Mild to moderate infusion-related fever and rigors were seen in 29 and 44% of patients, respectively. One patient each in the 3.75- and 7.5-mg groups had detectable parasites on splenic smear at posttreatment evaluation. At 6 months' follow-up, however, 2, 1, and 1 patients relapsed in the 3.75-, 7.5-, and 15.0-mg groups, resulting in definite cure rates of 89, 93, and 97%, respectively. There was no significant difference in the cure rates of the 3 groups. Low-dose liposomal amphotericin B given for 5 days can cure most patients with Indian kala-azar.

Save